Siemens Healthineers AG SHL.DE
Siemens Healthineers AG (SHL.DE) earns a Piotroski F-score of 9/9 (strong financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 2.78% (safety: moderate). FY2024 revenue was $22.4B at a 8.7% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 9/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.062 |
| Retained earnings / assets | 0.047 |
| EBIT / assets | 0.061 |
| Equity / liabilities | 0.654 |
FAQ
Is SHL.DE financially healthy?
Siemens Healthineers AG's Piotroski F-score is 9/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does SHL.DE pay a dividend, and is it safe?
Yes. Siemens Healthineers AG pays a dividend yielding about 2.78% with a 54.7% payout ratio, rated “moderate” for safety.
How profitable is SHL.DE?
In FY2024, Siemens Healthineers AG had a net margin of 8.7% and a return on equity of 10.7%.
Source: company filings via Yahoo Finance · DE · as of 2024-09-30. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.